BlueWillow Biologics is a privately-held biopharmaceutical company focused on developing and commercializing intranasal vaccines, based on its patented nanotechnology platform. Most infectious pathogens enter the body across mucosal surfaces. Yet few vaccines today provide mucosal immunity.

Website